by The global immunoassay market size accounted for US$ 32.46 Bn in 2022 and is projected to reach around USD 51.33 Bn by 2032, growing at a CAGR of 4.68% from 2023 to 2032.
Report Summary
The global immunoassay market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the immunoassay market across the globe.
A comprehensive estimate on the immunoassay market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of immunoassay during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2557
Immunoassay Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 33.98 Billion |
| Market Size by 2032 | USD 51.33 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 4.68% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Technology, By Specimen, By Application and By End User |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized immunoassay market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Sensor Market Size To Cross USD 508.64 Bn By 2032
Immunoassay Market Players
The report includes the profiles of key immunoassay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Abbott Laboratories
- Danaher Corporation (Beckman Coulter)
- Quidel Corporation
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
- Siemens Healthinners
Market Segmentation
By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagent & Kits
- ELISpot Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzer
- By Type
- Open-ended System
- Closed-Ended System
- By Purchased Mode
- Rental Purchased
- Outright Purchased
- By Type
- Software and Services
By Technology
- ELISA
- By generation
- Third generation & Above
- Second-generation & Below
- By generation
- Rapid Tests
- ELISpot
- Western Blotting
- Radioimmunoassay
- Other technologies
By Specimen
- Blood
- Saliva
- Urine
- Other Specimen
By Application
- Infectious diseases
- Endocrinology
- Oncology
- Bone and mineral disorders
- Cardiology
- Blood screening
- Autoimmune Disorders
- Allergy Diagnostics
- Toxicology
- Newborn Screening
- Other Application
By End-User
- Hospitals & Clinics
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies And Cro
- Blood Banks
- Research & Academic Laboratories
- Home Care Setting
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Immunoassay Market
5.1. COVID-19 Landscape: Immunoassay Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Immunoassay Market, By Product
8.1. Immunoassay Market, by Product, 2023-2032
8.1.1. Reagents & Kits
8.1.1.1. Market Revenue and Forecast (2023-2032)
8.1.2. Analyzer
8.1.2.1. Market Revenue and Forecast (2023-2032)
8.1.3. Software and Services
8.1.3.1. Market Revenue and Forecast (2023-2032)
Chapter 9. Global Immunoassay Market, By Technology
9.1. Immunoassay Market, by Technology, 2023-2032
9.1.1. ELISA
9.1.1.1. Market Revenue and Forecast (2023-2032)
9.1.2. Rapid Tests
9.1.2.1. Market Revenue and Forecast (2023-2032)
9.1.3. ELISpot
9.1.3.1. Market Revenue and Forecast (2023-2032)
9.1.4. Western Blotting
9.1.4.1. Market Revenue and Forecast (2023-2032)
9.1.5. Radioimmunoassay
9.1.5.1. Market Revenue and Forecast (2023-2032)
9.1.6. Other technologies
9.1.5.1. Market Revenue and Forecast (2023-2032)
Chapter 10. Global Immunoassay Market, By Specimen
10.1. Immunoassay Market, by Specimen, 2023-2032
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2023-2032)
10.1.2. Saliva
10.1.2.1. Market Revenue and Forecast (2023-2032)
10.1.3. Urine
10.1.3.1. Market Revenue and Forecast (2023-2032)
10.1.4. Other Specimen
10.1.4.1. Market Revenue and Forecast (2023-2032)
Chapter 11. Global Immunoassay Market, By Application
11.1. Immunoassay Market, by Application, 2023-2032
11.1.1. Infectious diseases
11.1.1.1. Market Revenue and Forecast (2023-2032)
11.1.2. Endocrinology
11.1.2.1. Market Revenue and Forecast (2023-2032)
11.1.3. Oncology
11.1.3.1. Market Revenue and Forecast (2023-2032)
11.1.4. Bone and mineral disorders
11.1.4.1. Market Revenue and Forecast (2023-2032)
11.1.5. Cardiology
11.1.5.1. Market Revenue and Forecast (2023-2032)
11.1.6. Blood screening
11.1.6.1. Market Revenue and Forecast (2023-2032)
11.1.7. Autoimmune Disorders
11.1.7.1. Market Revenue and Forecast (2023-2032)
11.1.8. Allergy Diagnostics
11.1.8.1. Market Revenue and Forecast (2023-2032)
11.1.9. Toxicology
11.1.9.1. Market Revenue and Forecast (2023-2032)
11.1.10. Newborn Screening
11.1.10.1. Market Revenue and Forecast (2023-2032)
11.1.11. Other Application
11.1.11.1. Market Revenue and Forecast (2023-2032)
Chapter 12. Global Immunoassay Market, By End-User
12.1. Immunoassay Market, by End-User, 2023-2032
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2023-2032)
12.1.2. Clinical Laboratories
12.1.2.1. Market Revenue and Forecast (2023-2032)
12.1.3. Pharmaceutical & Biotechnology Companies And Cro
12.1.3.1. Market Revenue and Forecast (2023-2032)
12.1.4. Blood Banks
12.1.4.1. Market Revenue and Forecast (2023-2032)
12.1.5. Research & Academic Laboratories
12.1.5.1. Market Revenue and Forecast (2023-2032)
12.1.6. Home Care Setting
12.1.6.1. Market Revenue and Forecast (2023-2032)
Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2023-2032)
13.1.2. Market Revenue and Forecast, by Technology (2023-2032)
13.1.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.1.4. Market Revenue and Forecast, by Application (2023-2032)
13.1.5. Market Revenue and Forecast, by End-User (2023-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2023-2032)
13.1.6.2. Market Revenue and Forecast, by Technology (2023-2032)
13.1.6.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.1.6.4. Market Revenue and Forecast, by Application (2023-2032)
13.1.6.5. Market Revenue and Forecast, by End-User (2023-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2023-2032)
13.1.7.2. Market Revenue and Forecast, by Technology (2023-2032)
13.1.7.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.1.7.4. Market Revenue and Forecast, by Application (2023-2032)
13.1.7.5. Market Revenue and Forecast, by End-User (2023-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2023-2032)
13.2.2. Market Revenue and Forecast, by Technology (2023-2032)
13.2.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.2.4. Market Revenue and Forecast, by Application (2023-2032)
13.2.5. Market Revenue and Forecast, by End-User (2023-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2023-2032)
13.2.6.2. Market Revenue and Forecast, by Technology (2023-2032)
13.2.6.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.2.7. Market Revenue and Forecast, by Application (2023-2032)
13.2.8. Market Revenue and Forecast, by End-User (2023-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2023-2032)
13.2.9.2. Market Revenue and Forecast, by Technology (2023-2032)
13.2.9.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.2.10. Market Revenue and Forecast, by Application (2023-2032)
13.2.11. Market Revenue and Forecast, by End-User (2023-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2023-2032)
13.2.12.2. Market Revenue and Forecast, by Technology (2023-2032)
13.2.12.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.2.12.4. Market Revenue and Forecast, by Application (2023-2032)
13.2.13. Market Revenue and Forecast, by End-User (2023-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2023-2032)
13.2.14.2. Market Revenue and Forecast, by Technology (2023-2032)
13.2.14.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.2.14.4. Market Revenue and Forecast, by Application (2023-2032)
13.2.15. Market Revenue and Forecast, by End-User (2023-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2023-2032)
13.3.2. Market Revenue and Forecast, by Technology (2023-2032)
13.3.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.3.4. Market Revenue and Forecast, by Application (2023-2032)
13.3.5. Market Revenue and Forecast, by End-User (2023-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2023-2032)
13.3.6.2. Market Revenue and Forecast, by Technology (2023-2032)
13.3.6.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.3.6.4. Market Revenue and Forecast, by Application (2023-2032)
13.3.7. Market Revenue and Forecast, by End-User (2023-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2023-2032)
13.3.8.2. Market Revenue and Forecast, by Technology (2023-2032)
13.3.8.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.3.8.4. Market Revenue and Forecast, by Application (2023-2032)
13.3.9. Market Revenue and Forecast, by End-User (2023-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2023-2032)
13.3.10.2. Market Revenue and Forecast, by Technology (2023-2032)
13.3.10.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.3.10.4. Market Revenue and Forecast, by Application (2023-2032)
13.3.10.5. Market Revenue and Forecast, by End-User (2023-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2023-2032)
13.3.11.2. Market Revenue and Forecast, by Technology (2023-2032)
13.3.11.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.3.11.4. Market Revenue and Forecast, by Application (2023-2032)
13.3.11.5. Market Revenue and Forecast, by End-User (2023-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2023-2032)
13.4.2. Market Revenue and Forecast, by Technology (2023-2032)
13.4.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.4.4. Market Revenue and Forecast, by Application (2023-2032)
13.4.5. Market Revenue and Forecast, by End-User (2023-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2023-2032)
13.4.6.2. Market Revenue and Forecast, by Technology (2023-2032)
13.4.6.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.4.6.4. Market Revenue and Forecast, by Application (2023-2032)
13.4.7. Market Revenue and Forecast, by End-User (2023-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2023-2032)
13.4.8.2. Market Revenue and Forecast, by Technology (2023-2032)
13.4.8.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.4.8.4. Market Revenue and Forecast, by Application (2023-2032)
13.4.9. Market Revenue and Forecast, by End-User (2023-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2023-2032)
13.4.10.2. Market Revenue and Forecast, by Technology (2023-2032)
13.4.10.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.4.10.4. Market Revenue and Forecast, by Application (2023-2032)
13.4.10.5. Market Revenue and Forecast, by End-User (2023-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2023-2032)
13.4.11.2. Market Revenue and Forecast, by Technology (2023-2032)
13.4.11.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.4.11.4. Market Revenue and Forecast, by Application (2023-2032)
13.4.11.5. Market Revenue and Forecast, by End-User (2023-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2023-2032)
13.5.2. Market Revenue and Forecast, by Technology (2023-2032)
13.5.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.5.4. Market Revenue and Forecast, by Application (2023-2032)
13.5.5. Market Revenue and Forecast, by End-User (2023-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2023-2032)
13.5.6.2. Market Revenue and Forecast, by Technology (2023-2032)
13.5.6.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.5.6.4. Market Revenue and Forecast, by Application (2023-2032)
13.5.7. Market Revenue and Forecast, by End-User (2023-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2023-2032)
13.5.8.2. Market Revenue and Forecast, by Technology (2023-2032)
13.5.8.3. Market Revenue and Forecast, by Specimen (2023-2032)
13.5.8.4. Market Revenue and Forecast, by Application (2023-2032)
13.5.8.5. Market Revenue and Forecast, by End-User (2023-2032)
Chapter 14. Company Profiles
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Danaher Corporation (Beckman Coulter)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Quidel Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ortho Clinical Diagnostics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Sysmex Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Becton, Dickinson, and Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. F. Hoffmann-La Roche AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Thermo Fisher Scientific, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Siemens Healthinners
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
